Temporal estimates of case-fatality rate for COVID-19 outbreaks in Canada and the United States

被引:49
作者
Abdollahi, Elaheh [1 ]
Champredon, David [2 ]
Langley, Joanne M. [3 ,4 ]
Galvani, Alison P. [5 ]
Moghadas, Seyed M. [1 ]
机构
[1] York Univ, Agent Based Modelling Lab, Toronto, ON, Canada
[2] Western Univ, Dept Pathol & Lab Med, London, ON, Canada
[3] Dalhousie Univ, Canadian Ctr Vaccinol, IWK Hlth Ctr, Halifax, NS, Canada
[4] Nova Scotia Hlth Author, Halifax, NS, Canada
[5] Yale Sch Publ Hlth, Ctr Infect Dis Modeling & Anal, New Haven, CT USA
基金
加拿大自然科学与工程研究理事会; 加拿大健康研究院; 美国国家卫生研究院;
关键词
D O I
10.1503/cmaj.200711
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Estimates of the case-fatality rate (CFR) associated with coronavirus disease 2019 (COVID-19) vary widely in different population settings. We sought to estimate and compare the COVID-19 CFR in Canada and the United States while adjusting for 2 potential biases in crude CFR. METHODS: We used the daily incidence of confirmed COVID-19 cases and deaths in Canada and the US from Jan. 31 to Apr. 22, 2020. We applied a statistical method to minimize bias in the crude CFR by accounting for the survival interval as the lag time between disease onset and death, while considering reporting rates of COVID-19 cases less than 50% (95% confidence interval 10%-50%). RESULTS: Using data for confirmed cases in Canada, we estimated the crude CFR to be 4.9% on Apr. 22, 2020, and the adjusted CFR to be 5.5% (credible interval [CrI] 4.9%-6.4%). After we accounted for various reporting rates less than 50%, the adjusted CFR was estimated at 1.6% (CrI 0.7%-3.1%). The US crude CFR was estimated to be 5.4% on Apr. 20, 2020, with an adjusted CFR of 6.1% (CrI 5.4%-6.9%). With reporting rates of less than 50%, the adjusted CFR for the US was 1.78 (CrI 0.8%-3.6%). INTERPRETATION: Our estimates suggest that, if the reporting rate is less than 50%, the adjusted CFR of COVID-19 in Canada is likely to be less than 2%. The CFR estimates for the US were higher than those for Canada, but the adjusted CFR still remained below 2%. Quantification of case reporting can provide a more accurate measure of the virulence and disease burden of severe acute respiratory syndrome coronavirus 2.
引用
收藏
页码:E666 / E670
页数:5
相关论文
共 21 条
[1]  
[Anonymous], COR CAS US
[2]  
[Anonymous], Public COVID-19 Data for Norway (covid19data.no). COVID-19 data
[3]  
[Anonymous], 2020, ESTIMATING POTENTIAL
[4]   Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State [J].
Arentz, Matt ;
Yim, Eric ;
Klaff, Lindy ;
Lokhandwala, Sharukh ;
Riedo, Francis X. ;
Chong, Maria ;
Lee, Melissa .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (16) :1612-1614
[5]  
Bendavid E, 2020, COVID 19 ANTIBODY SE, DOI 10.1101/2020.04.14.20062463
[6]   Covid-19 in Critically Ill Patients in the Seattle Region - Case Series [J].
Bhatraju, Pavan K. ;
Ghassemieh, Bijan J. ;
Nichols, Michelle ;
Kim, Richard ;
Jerome, Keith R. ;
Nalla, Arun K. ;
Greninger, Alexander L. ;
Pipavath, Sudhakar ;
Wurfel, Mark M. ;
Evans, Laura ;
Kritek, Patricia A. ;
West, T. Eoin ;
Luks, Andrew ;
Gerbino, Anthony ;
Dale, Chris R. ;
Goldman, Jason D. ;
O'Mahony, Shane ;
Mikacenic, Carmen .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (21) :2012-2022
[7]  
Chowell G., 2020, SPATIAL VARIABILITY, DOI [10.1101/2020.04.01.20049668, DOI 10.1101/2020.04.01.20049668]
[8]   Assessing the severity of the novel influenza A/H1N1 pandemic [J].
Garske, Tini ;
Legrand, Judith ;
Donnelly, Christl A. ;
Ward, Helen ;
Cauchemez, Simon ;
Fraser, Christophe ;
Ferguson, Neil M. ;
Ghani, Azra C. .
BRITISH MEDICAL JOURNAL, 2009, 339 :220-224
[9]  
Gilmour S., 2020, Bull. World Health Organ, DOI [10.2471/BLT.20.254565, DOI 10.2471/BLT.20.254565]
[10]  
Li LQ, 2020, J MED VIROL, V92, P577, DOI [10.1002/jmv.25757, 10.1016/j.jnlest.2020.100045]